The Warren Buffett derivative trading mystery grows, as Bloomberg’s Matt Levine takes aim at FT Alphaville series written by Dan McCrum and raises questions.
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
|
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.
A growing counter-trend is beginning to take shape amid the Trump rally, Paul Brodsky of the research service Macro Allocation Incorporated (MAI) notes. While the loud consensus explains certain... Read More
As the stock market collapses in part on concerns regarding the reduction of quantitative easing into the economy, the U.S. Federal Reserve (Fed) says the core economy is on... Read More
Misperceptions Of Thailand by Tarik Jaleel, CFA - Matthews Asia On a recent research trip to Thailand, I had the chance to evaluate some commonly held misperceptions about the long-term... Read More
We believe that shares of Mellanox Technologies, Ltd. (NASDAQ:MLNX) are highly overvalued, not only because it is a semiconductor company operating in a small and technologically fast-changing niche trading at... Read More
Society is reaching an automation inflection point as robotic surgery is set to introduce cost reductions and quality improvement to a sector where a highly skilled and educated workforce is... Read More
It’s a cruel paradox. Social networks and crowd-funding sites now empower entrepreneurs. Smart ideas, innovative concepts and creative inventions are more plentiful than ever. Yet in a time of... Read More
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) and Bill Ackman’s Pershing Square are said to be planning to boost their offer to acquire Botox maker Allergan, Inc. (NYSE:AGN) by $15 a... Read More
Fresh off the heels of a California Judge imposing a $6.8 million judgment against Overstock.com, Inc. (NASDAQ:OSTK) for false advertising and unlawful business practices, the company is in trouble again.... Read More
Argentina's president Cristina Fernández de Kirchner addressed the United Nations today with a firm tone and pointed to global support in her fight with “vulture” hedge funds, then expressed... Read More
Want to purchase the right’s to a celebrities future success? Fantex, the exchange method that allows investors to get a piece of an athlete’s future earnings, has its eye... Read More
